AMY BANAHAN: Open Payments
NPI 1265278758 · SLINGERLANDS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$315 in 15 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $374 · 2025 $315
Food & beverage: $315
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| KYOWA KIRIN, INC. | 1 | $29 |
| Exact Sciences Corporation | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Optinose US, Inc. | 1 | $18 |
Products named: Kerendia, CAPLYTA, CRYSVITA, The Cologuard Plus Collection Kit, Wegovy, TRELEGY ELLIPTA, Veozah, Auvelity.
Industry payments across NY — which companies pay providers there.
